Cargando…
Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents
Severe traumatic brain injury (TBI), such as that suffered by patients with cerebral contusion, is a major cause of death and disability in young persons. Effective therapeutics to treat or mitigate the effects of severe TBI are lacking, in part because drug delivery to the injured brain remains a c...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985535/ https://www.ncbi.nlm.nih.gov/pubmed/35403102 http://dx.doi.org/10.1089/neur.2021.0049 |
_version_ | 1784682381719896064 |
---|---|
author | Whitener, Ricky Henchir, Jeremy J. Miller, Thomas A. Levy, Emily Krysiewicz-Bell, Aubrienne Abrams, Eliza S. LaRovere Carlson, Shaun W. Menon, Naresh Dixon, C. Edward Whalen, Michael J. Rogers, Claude J. |
author_facet | Whitener, Ricky Henchir, Jeremy J. Miller, Thomas A. Levy, Emily Krysiewicz-Bell, Aubrienne Abrams, Eliza S. LaRovere Carlson, Shaun W. Menon, Naresh Dixon, C. Edward Whalen, Michael J. Rogers, Claude J. |
author_sort | Whitener, Ricky |
collection | PubMed |
description | Severe traumatic brain injury (TBI), such as that suffered by patients with cerebral contusion, is a major cause of death and disability in young persons. Effective therapeutics to treat or mitigate the effects of severe TBI are lacking, in part because drug delivery to the injured brain remains a challenge. Promising therapeutics targeting secondary injury mechanisms may have poor pharmacokinetics/pharmacodynamics, unwanted side effects, or high hydrophobicity. To address these challenges, we have developed a multi-lamellar vesicle nanoparticle (MLV-NP) formulation with a narrow size distribution (243 nm in diameter, 0.09 polydispersity index) and the capability of encapsulating hydrophobic small molecule drugs for delivery to the injured brain. To demonstrate the utility of these particles, we produced dual-fluorescent labeled nanoparticles containing the organic dyes, coumarin 153 and rhodamine B, that were delivered intravenously to Sprague-Dawley rats and C57Bl6/J mice at 1, 1 and 4, 24, or 48 h after controlled cortical impact injury. Distribution of particles was measured at 5, 25, 48, or 49 h post-injury by fluorescence microscopy of coronal brain sections. In all cases of MLV administration, a 1.2- to 1.9-fold enhancement of ipsilateral fluorescence signal was observed compared to the contralateral cortex. Enhanced fluorescence was also observed in the injured hippocampal tissue in these animals. MLV-NPs administered at 1 h were observed intracellularly in the injured hemisphere at 48 h, suggesting the possibility of concentrated drug delivery to injured cells. These results suggest that MLV-NP delivery of therapeutic agents may be a viable strategy for treating cerebral contusion TBI. |
format | Online Article Text |
id | pubmed-8985535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-89855352022-04-07 Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents Whitener, Ricky Henchir, Jeremy J. Miller, Thomas A. Levy, Emily Krysiewicz-Bell, Aubrienne Abrams, Eliza S. LaRovere Carlson, Shaun W. Menon, Naresh Dixon, C. Edward Whalen, Michael J. Rogers, Claude J. Neurotrauma Rep Original Article Severe traumatic brain injury (TBI), such as that suffered by patients with cerebral contusion, is a major cause of death and disability in young persons. Effective therapeutics to treat or mitigate the effects of severe TBI are lacking, in part because drug delivery to the injured brain remains a challenge. Promising therapeutics targeting secondary injury mechanisms may have poor pharmacokinetics/pharmacodynamics, unwanted side effects, or high hydrophobicity. To address these challenges, we have developed a multi-lamellar vesicle nanoparticle (MLV-NP) formulation with a narrow size distribution (243 nm in diameter, 0.09 polydispersity index) and the capability of encapsulating hydrophobic small molecule drugs for delivery to the injured brain. To demonstrate the utility of these particles, we produced dual-fluorescent labeled nanoparticles containing the organic dyes, coumarin 153 and rhodamine B, that were delivered intravenously to Sprague-Dawley rats and C57Bl6/J mice at 1, 1 and 4, 24, or 48 h after controlled cortical impact injury. Distribution of particles was measured at 5, 25, 48, or 49 h post-injury by fluorescence microscopy of coronal brain sections. In all cases of MLV administration, a 1.2- to 1.9-fold enhancement of ipsilateral fluorescence signal was observed compared to the contralateral cortex. Enhanced fluorescence was also observed in the injured hippocampal tissue in these animals. MLV-NPs administered at 1 h were observed intracellularly in the injured hemisphere at 48 h, suggesting the possibility of concentrated drug delivery to injured cells. These results suggest that MLV-NP delivery of therapeutic agents may be a viable strategy for treating cerebral contusion TBI. Mary Ann Liebert, Inc., publishers 2022-04-05 /pmc/articles/PMC8985535/ /pubmed/35403102 http://dx.doi.org/10.1089/neur.2021.0049 Text en © Ricky Whitener et al., 2022; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Whitener, Ricky Henchir, Jeremy J. Miller, Thomas A. Levy, Emily Krysiewicz-Bell, Aubrienne Abrams, Eliza S. LaRovere Carlson, Shaun W. Menon, Naresh Dixon, C. Edward Whalen, Michael J. Rogers, Claude J. Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents |
title | Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents |
title_full | Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents |
title_fullStr | Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents |
title_full_unstemmed | Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents |
title_short | Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents |
title_sort | localization of multi-lamellar vesicle nanoparticles to injured brain tissue in a controlled cortical impact injury model of traumatic brain injury in rodents |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985535/ https://www.ncbi.nlm.nih.gov/pubmed/35403102 http://dx.doi.org/10.1089/neur.2021.0049 |
work_keys_str_mv | AT whitenerricky localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT henchirjeremyj localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT millerthomasa localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT levyemily localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT krysiewiczbellaubrienne localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT abramselizaslarovere localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT carlsonshaunw localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT menonnaresh localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT dixoncedward localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT whalenmichaelj localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents AT rogersclaudej localizationofmultilamellarvesiclenanoparticlestoinjuredbraintissueinacontrolledcorticalimpactinjurymodeloftraumaticbraininjuryinrodents |